Windlas Biotech is a Pharma company which provides CDMO service with Market cap pf 881 Cr.
P/E 18.8 vs Industry P/E 32
Quarterly sale & operating profit is improving
Technically Chart has completed it cup handle pattern and given the breakout which is been retested. Look good to accumulate for ATH Target. one can expect 30 to 40% from this.